NRSN
Price
$0.47
Change
-$0.01 (-2.08%)
Updated
Jul 31 closing price
Capitalization
16.79M
30 days until earnings call
Intraday BUY SELL Signals
SLXN
Price
$1.88
Change
+$0.04 (+2.17%)
Updated
Jul 31 closing price
Capitalization
2M
15 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NRSN vs SLXN

NRSN vs SLXN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NRSN vs. SLXN commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRSN is a StrongBuy and SLXN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (NRSN: $0.47 vs. SLXN: $1.88)
Brand notoriety: NRSN and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRSN: 45% vs. SLXN: 47%
Market capitalization -- NRSN: $16.79M vs. SLXN: $2M
NRSN [@Biotechnology] is valued at $16.79M. SLXN’s [@Biotechnology] market capitalization is $2M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRSN’s FA Score shows that 0 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • NRSN’s FA Score: 0 green, 5 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, SLXN is a better buy in the long-term than NRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRSN’s TA Score shows that 4 TA indicator(s) are bullish while SLXN’s TA Score has 4 bullish TA indicator(s).

  • NRSN’s TA Score: 4 bullish, 4 bearish.
  • SLXN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SLXN is a better buy in the short-term than NRSN.

Price Growth

NRSN (@Biotechnology) experienced а -22.74% price change this week, while SLXN (@Biotechnology) price change was -17.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.22%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +2790.29%.

Reported Earning Dates

NRSN is expected to report earnings on Sep 02, 2026.

SLXN is expected to report earnings on Aug 18, 2026.

Industries' Descriptions

@Biotechnology (-1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRSN($16.8M) has a higher market cap than SLXN($2M). NRSN YTD gains are higher at: -39.506 vs. SLXN (-90.208). NRSN has higher annual earnings (EBITDA): -8.55M vs. SLXN (-12.91M). SLXN has more cash in the bank: 2.41M vs. NRSN (666K). NRSN has less debt than SLXN: NRSN (19K) vs SLXN (1.99M). NRSN (0) and SLXN (0) have equivalent revenues.
NRSNSLXNNRSN / SLXN
Capitalization16.8M2M840%
EBITDA-8.55M-12.91M66%
Gain YTD-39.506-90.20844%
P/E RatioN/A0.00-
Revenue00-
Total Cash666K2.41M28%
Total Debt19K1.99M1%
TECHNICAL ANALYSIS
Technical Analysis
NRSNSLXN
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
51%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
38%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
36%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
65%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
76%
Advances
ODDS (%)
Bullish Trend 22 days ago
88%
Bullish Trend 4 days ago
55%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
61%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
NRSN
Daily Signal:
Gain/Loss:
SLXN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRCT2.530.04
+1.61%
Direct Digital Holdings Inc.
COFS34.030.20
+0.59%
ChoiceOne Financial Services
ATAI7.18N/A
N/A
AtaiBeckley Inc
CNA52.47-0.79
-1.48%
CNA Financial Corp
MNTS4.05-0.47
-10.40%
Momentus Inc.

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
+2.17%
IMA - SLXN
62%
Loosely correlated
-6.26%
CELC - SLXN
50%
Loosely correlated
-1.44%
CDT - SLXN
44%
Loosely correlated
+9.33%
IMVT - SLXN
40%
Loosely correlated
-2.18%
INKT - SLXN
36%
Loosely correlated
-0.85%
More